History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study
- PMID: 28376160
- PMCID: PMC5441298
- DOI: 10.1093/jnci/djw268
History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study
Abstract
Background: The association between history of keratinocyte carcinoma (KC, also known as nonmelanoma skin cancer) and risk of developing invasive melanoma has not been assessed comprehensively using prospective data.
Methods: We followed 91 846 women in the Nurses' Health Study (NHS; 1984-2010), 114 918 women in the NHSII (1989-2011), and 48 946 men in the Health Professionals Follow-up Study (1986-2010) for diagnoses of KC and melanoma biennially. Cox proportional hazards models were used to compute hazard ratios (HRs) and 95% confidence intervals (CIs) of melanoma associated with history of KC, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC). All statistical tests were two-sided.
Results: We documented 1949 melanomas, 38 842 BCCs, and 7462 SCCs over 6.4 million person-years of follow-up. After adjustment for other risk factors, a personal history of KC was associated with an increased risk of melanoma (meta-analysis HR = 2.22, 95% CI = 1.73 to 2.85). The association was more apparent among participants with a history of both BCC and SCC (HR = 3.40, 95% CI = 1.60 to 7.19) than among participants with a history of BCC only (HR = 2.20, 95% CI = 1.80 to 2.70) or SCC only (HR = 1.56, 95% CI = 0.98 to 2.46), and there was a strong risk-increasing trend associated with a higher number of reported KCs removed by surgery ( P trend < .001). In women, KC history was more strongly associated with head/neck melanomas (HR = 4.17, 95% CI = 2.77 to 6.27) than with trunk or limb melanomas (both HRs < 2.50, P heterogeneity = .04).
Conclusions: Our results provide novel insights for the relationship between KC history and risk of developing melanoma, which may be important for melanoma prevention.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias.JAMA Dermatol. 2019 Mar 1;155(3):353-357. doi: 10.1001/jamadermatol.2018.4216. JAMA Dermatol. 2019. PMID: 30586131 Free PMC article.
-
Having a first-degree relative with melanoma increases lifetime risk of melanoma, squamous cell carcinoma, and basal cell carcinoma.J Am Acad Dermatol. 2019 Aug;81(2):489-499. doi: 10.1016/j.jaad.2019.04.044. Epub 2019 Jun 21. J Am Acad Dermatol. 2019. PMID: 31230976
-
Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.JAMA Dermatol. 2015 Apr;151(4):382-8. doi: 10.1001/jamadermatol.2014.3307. JAMA Dermatol. 2015. PMID: 25588079
-
Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype.Adv Cancer Res. 2016;130:257-91. doi: 10.1016/bs.acr.2016.01.003. Epub 2016 Feb 23. Adv Cancer Res. 2016. PMID: 27037755 Review.
-
Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.Adv Exp Med Biol. 2008;624:89-103. doi: 10.1007/978-0-387-77574-6_8. Adv Exp Med Biol. 2008. PMID: 18348450 Review.
Cited by
-
Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study.Acta Derm Venereol. 2023 Jan 5;103:adv00841. doi: 10.2340/actadv.v103.4402. Acta Derm Venereol. 2023. PMID: 36600530 Free PMC article.
-
Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility.JCI Insight. 2018 Aug 9;3(15):e122744. doi: 10.1172/jci.insight.122744. eCollection 2018 Aug 9. JCI Insight. 2018. PMID: 30089731 Free PMC article.
-
COX-2 inhibitors show no preventive effect in the development of skin cancer.J Dtsch Dermatol Ges. 2022 Feb;20(2):157-166. doi: 10.1111/ddg.14649. Epub 2022 Jan 27. J Dtsch Dermatol Ges. 2022. PMID: 35088518 Free PMC article.
-
Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities.Molecules. 2020 Nov 18;25(22):5398. doi: 10.3390/molecules25225398. Molecules. 2020. PMID: 33218174 Free PMC article. Review.
-
Incidence and mortality rates of keratinocyte carcinoma from 1998-2017: a population-based study of sex differences in Ontario, Canada.CMAJ. 2021 Oct 4;193(39):E1516-E1524. doi: 10.1503/cmaj.210595. CMAJ. 2021. PMID: 34607845 Free PMC article.
References
-
- American Cancer Society. Cancer Facts & Figures 2014. Atlanta, GA: American Cancer Society; 2014.
-
- Parkin DM, Bray F, Ferlay J, Pisani P.. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- American Cancer Society. Skin cancer: Basal and squamous cell. What are the key statistics about basal and squamous cell skin cancers? 2014. http://www.cancer.org/cancer/skincancer-basalandsquamouscell/detailedgui.... Accessed November 26, 2014.
-
- Guy GP, Ekwueme DU.. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: A systematic review of the literature. PharmacoEconomics. 2011;29:863–874. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials